Publications:

KIF11 manipulates SREBP2-dependent mevalonate cross talk to promote tumor progression in pancreatic ductal adenocarcinoma.

Cancer Medicine

Gu, Xiang X; Zhu, Qunshan Q; Tian, Guangyu G; Song, Wenbo W; Wang, Tao T; Wang, Ali A; Chen, Xiaojun X; Qin, Songbing S

Publication Date: 2022-09

Variant appearance in text: F2: a16e

PubMed Link: 35619540

Variant Present in the following documents:

• CAM4-11-3282-s001.xls, sheet 1

View BVdb publication page

A Prognostic Prediction Model Developed Based on Four CpG Sites and Weighted Correlation Network Analysis Identified DNAJB1 as a Novel Biomarker for Pancreatic Cancer.

Frontiers In Oncology

Kong, Lingming L; Liu, Peng P; Fei, Xiang X; Wu, Tianyu T; Wang, Zhongpeng Z; Zhang, Baohui B; Li, Jiatong J; Tan, Xiaodong X

Publication Date: 2020

Variant appearance in text: F2: a16e

PubMed Link: 32984053

Variant Present in the following documents:

• Data_Sheet_2.xlsx, sheet 1

View BVdb publication page